Brazil · Delayed Price · Currency is BRL Yduqs Participações Earnings Call Transcripts
Fiscal Year 2026
-
Record cash generation and strong growth in premium brands Ibmec and Idomed drove robust Q1 2026 results, with improved margins, lower bad debt, and a solid outlook for continued cash flow and profitability. Regulatory changes and macroeconomic headwinds were offset by portfolio strength and disciplined capital allocation.
Fiscal Year 2025
-
Strong cash generation and margin expansion in 2025 were driven by Premium segment growth and operational efficiencies, with leverage reduction and consistent dividends prioritized. Regulatory changes and macroeconomic headwinds impacted intake mix, but outlook for 2026 remains positive, with further deleveraging and stable margins expected.
-
Q3 2025 saw strong revenue and margin growth, robust cash generation, and reduced leverage, with premium brands driving results. Regulatory changes are expected to have limited impact, while investments in technology and operational efficiency support a positive outlook for 2026.
-
Leadership transition completed with strong cash generation and premium segment growth driving results. Revenue, net income, and cash flow all increased year-over-year, with guidance reaffirmed for a robust second half. Regulatory clarity and M&A support future expansion.
-
A seamless CEO transition is underway, with strong alignment on values and strategy, ensuring continuity. The company maintains its strategic focus on innovation, cash generation, and disciplined capital allocation, with no changes to guidance. AI and technology remain central to future growth.
-
Cash generation surged 31% year-over-year, driven by premium segment growth and operational improvements. Guidance for 2025 FCFE is BRL 500–600 million, with EPS expected to rise and leverage declining. Premium units and semi-on campus offerings are key growth drivers.
Fiscal Year 2024
-
Adjusted EBITDA grew 6% and net income rose 40% year-over-year, with strong cash generation and margin expansion. Premium segments led growth, while strategic buybacks, dividends, and acquisitions enhanced shareholder value. Leverage declined and 2025 outlook is positive.
-
Second quarter and first half 2024 results showed revenue, EBITDA, and net income growth, driven by premium and digital segments, with student base expansion and strong cost control. Guidance for the year is reaffirmed, with margin recovery and improved efficiency expected in the second half.